LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

Kodu・Aktsiate loetelu・Gossamer Bio Inc

Gossamer Bio Inc

Suletud

SektorTervishoid

1.18 2.61

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

1.17

Max

1.18

Põhinäitajad
By Trading Economics
Sissetulek	-3.6M -37M
Müük	510K 9.9M
Aktsiakasum	-0.16
Kasumimarginaal	-370.492
Töötajad	144
EBITDA	-5.2M -37M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+629.17% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	8. aug 2025

Turustatistika
By TradingEconomics
Turukapital	-2.3M 248M
Eelmine avamishind	-1.43
Eelmine sulgemishind	1.18

Uudiste sentiment

By Acuity

25%

75%

53 / 381 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

1.06 / 1.23 Toetus ja vastupanu

Gossamer Bio Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

23. mai 2025, 20:33 UTC

Omandamised, ülevõtmised, äriostud

Salesforce in Talks to Buy Informatica, Bloomberg Reports, Citing Sources

24. mai 2025, 08:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

24. mai 2025, 08:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

24. mai 2025, 07:00 UTC

Tulu

Retailers Are Giving Mixed Messages on Prices. What Will s Really Happen at Checkout. -- Barrons.com

23. mai 2025, 21:57 UTC

Kuumad aktsiad

Stocks to Watch: Apple, Booz Allen, Constellation Energy, Intuit -- WSJ

23. mai 2025, 21:15 UTC

Peamised uudised

Trump Threatens Fresh Tariffs on EU, iPhones and Rival Devices -- 4th Update

23. mai 2025, 21:04 UTC

Omandamised, ülevõtmised, äriostud

Real-Estate Broker Douglas Elliman Could See Takeover Battle After Report of Bid -- Barrons.com

23. mai 2025, 20:56 UTC

Peamised uudised

Omandamised, ülevõtmised, äriostud

Salesforce Back in Deal Talks With Informatica -- WSJ

23. mai 2025, 20:51 UTC

Peamised uudised

Boeing in Tentative Agreement to Pay $1.1 Billion to Avoid Trial for 737 MAX Crashes -- WSJ

23. mai 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

23. mai 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

23. mai 2025, 20:41 UTC

Peamised uudised

Stocks Fall on Tariff Broadside, After Week of Bond Market Agita -- WSJ

23. mai 2025, 20:28 UTC

Peamised uudised

Trump Threatens EU With 50% Tariffs, Takes Aim at Apple; Nasdaq Drops -- WSJ

23. mai 2025, 20:06 UTC

Peamised uudised

Trump Threatens Fresh Tariffs on EU, iPhones and Rival Devices -- 5th Update

23. mai 2025, 20:06 UTC

Omandamised, ülevõtmised, äriostud

Salesforce Stock Drops, Informatica Soars. A Deal May Be Back on the Table. -- Barrons.com

23. mai 2025, 19:50 UTC

Peamised uudised

Trump's Tariffs: Where Things Stand -- 16th Update

23. mai 2025, 19:28 UTC

Omandamised, ülevõtmised, äriostud

Trump on Truth Social: 'Bulk of That Investment Will Occur in the Next 14 Months'

23. mai 2025, 19:28 UTC

Omandamised, ülevõtmised, äriostud

Trump on Truth Social: 'This Will Be a Planned Partnership Between United States Steel and Nippon Steel'

23. mai 2025, 19:27 UTC

Omandamised, ülevõtmised, äriostud

Trump on Truth Social: 'Proud to Announce That, After Much Consideration and Negotiation, US Steel Will REMAIN in America'

23. mai 2025, 19:20 UTC

Market Talk

Crude Futures Post Modest Weekly Losses -- Market Talk

23. mai 2025, 19:18 UTC

Market Talk

U.S. Natural Gas Futures End Week Unchanged -- Market Talk

23. mai 2025, 18:57 UTC

Peamised uudised

Trump Threatens Fresh Tariffs on EU, iPhones and Rival Devices -- 4th Update

23. mai 2025, 18:54 UTC

Peamised uudised

Trump Threatens Fresh Tariffs on EU, iPhones and Rival Devices -- Update

23. mai 2025, 18:53 UTC

Peamised uudised

Omandamised, ülevõtmised, äriostud

McDonald's Bids Goodbye to CosMc's, Its Space Alien-Themed Spinoff -- WSJ

23. mai 2025, 18:52 UTC

Omandamised, ülevõtmised, äriostud

DDC Enterprise Issues 254,333 Class A Ordinary Shrs in Exchange for 21 BTC, Valued at About $2.28M in Current Market Price

23. mai 2025, 18:13 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

23. mai 2025, 18:13 UTC

Market Talk

Gold Trades Higher on Reminder of Risk -- Market Talk

23. mai 2025, 18:00 UTC

Peamised uudised

Apple's Stock Still Not Pricing in Trump's Demands - Heard on the Street -- WSJ

23. mai 2025, 17:51 UTC

Market Talk

Tulu

Workday Sees Higher Bar for Guidance -- Market Talk

23. mai 2025, 17:42 UTC

Peamised uudised

Dow Drops, Trump Threatens EU With 50% Tariffs, Takes Aim at Apple -- WSJ

Võrdlus sarnastega

Hinnamuutus

Gossamer Bio Inc Prognoos

Hinnasiht

By TipRanks

629.17% tõus

12 kuu keskmine prognoos

Keskmine 8.75 USD 629.17%

Kõrge 15 USD

Madal 4 USD

Põhineb 6 Wall Streeti analüütiku instrumendi Gossamer Bio Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

6 ratings

Osta

Hoia

Müü

Põhineb 6 analüütiku instrumendi Gossamer Bio Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

1.06 / 1.23Toetus ja vastupanu

Bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

All events are bullish.

Sentiment

By Acuity

53 / 381 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Gossamer Bio Inc

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California.